Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Warner

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Platelets|August 3, 2011
Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readingsMelissa V Chan, Timothy D Warner
Pharmacology & Therapeutics|July 19, 2011
Gasotransmitters and plateletsNicola J Truss, Timothy D Warner
British Journal of Clinical Pharmacology|February 16, 2011
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyTimothy D Warner, Sven Nylander, Carl Whatling
Circulation Research|August 10, 2002
Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapyDavid Bishop-Bailey, Timothy Hla, Timothy D Warner
JRSM Cardiovascular Disease|February 10, 2016
Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet functionChristopher N Floyd, Albert Ferro, Timothy D Warner
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul AssayMelissa V Chan, Marie Lordkipanidzé, Timothy D Warner
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
COX-2 in cardiovascular diseaseDavid Bishop-Bailey, Jane A Mitchell, Timothy D Warner
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Expression and activation of the farnesoid X receptor in the vasculatureDavid Bishop-Bailey, Desmond T Walsh, Timothy D Warner
Platelets|March 16, 2018
96-well plate-based aggregometryMelissa V Chan, Paul C Armstrong, Timothy D Warner
Lancet (London, England)|November 30, 2002
Cyclo-oxygenase-2 inhibitors and cardiovascular eventsTimothy D Warner, Jane A Mitchell, John R Vane
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Platelets|August 3, 2011
Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readingsMelissa V Chan, Timothy D Warner
Pharmacology & Therapeutics|July 19, 2011
Gasotransmitters and plateletsNicola J Truss, Timothy D Warner
British Journal of Clinical Pharmacology|February 16, 2011
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyTimothy D Warner, Sven Nylander, Carl Whatling
Circulation Research|August 10, 2002
Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapyDavid Bishop-Bailey, Timothy Hla, Timothy D Warner
JRSM Cardiovascular Disease|February 10, 2016
Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet functionChristopher N Floyd, Albert Ferro, Timothy D Warner
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul AssayMelissa V Chan, Marie Lordkipanidzé, Timothy D Warner
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
COX-2 in cardiovascular diseaseDavid Bishop-Bailey, Jane A Mitchell, Timothy D Warner
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Expression and activation of the farnesoid X receptor in the vasculatureDavid Bishop-Bailey, Desmond T Walsh, Timothy D Warner
Platelets|March 16, 2018
96-well plate-based aggregometryMelissa V Chan, Paul C Armstrong, Timothy D Warner
Lancet (London, England)|November 30, 2002
Cyclo-oxygenase-2 inhibitors and cardiovascular eventsTimothy D Warner, Jane A Mitchell, John R Vane
Pageof 12